Cloning and Partial Characterization of an Endo-α-(1→6)-d-Mannanase Gene from .

Int J Mol Sci

Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523-1682, USA.

Published: December 2019

Mycobacteria produce two major lipoglycans, lipomannan (LM) and lipoarabinomannan (LAM), whose broad array of biological activities are tightly related to the fine details of their structure. However, the heterogeneity of these molecules in terms of internal and terminal covalent modifications and complex internal branching patterns represent significant obstacles to their structural characterization. Previously, an endo-α-(1→6)-D-mannanase from proved useful in cleaving the mannan backbone of LM and LAM, allowing the reducing end of these molecules to be identified as Man-(1→6) [Man-(1→2)]-Ino. Although first reported 45 years ago, no easily accessible form of this enzyme was available to the research community, a fact that may in part be explained by a lack of knowledge of its complete gene sequence. Here, we report on the successful cloning of the complete endo-α-(1→6)-D-mannanase gene from TN-31, herein referred to as . We further report on the successful production and purification of the glycosyl hydrolase domain of this enzyme and its use to gain further insight into its substrate specificity using synthetic mannoside acceptors as well as LM and phosphatidyl--inositol mannoside precursors purified from mycobacteria.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940960PMC
http://dx.doi.org/10.3390/ijms20246244DOI Listing

Publication Analysis

Top Keywords

characterization endo-α-1→6-d-mannanase
8
endo-α-1→6-d-mannanase gene
8
report successful
8
cloning partial
4
partial characterization
4
gene mycobacteria
4
mycobacteria produce
4
produce major
4
major lipoglycans
4
lipoglycans lipomannan
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!